Certificate of Analysis · CJC-1295/Ipamorelin · Certificate reference 060718

Name: Certificate of Analysis · CJC-1295/Ipamorelin · Certificate reference 060718
Creator: BT Labs

The laboratory's own sample ID for this analysis is BTL260812-009-002.

Independent third-party testing by BT Labs, West Palm Beach, FL. Each report links to the lab's own verification copy.

Laboratory: BT Labs, 5601 Corporate Way, Suite 206, West Palm Beach, FL 33407

BT Labs asks for a name and a quick check before it shows a report.

Purity & Potency (HPLC / FTIR)

Report COA261149-002Tested 8/27/2026Sample BTL260812-009-002

Result

Purity · HPLC at 280 nm: 99.9% (laboratory specification 98%)
Identity · FTIR, USP <197A>: CJC-1295, Ipamorelin, Confirmed
Labelled content: 20 mg
Assayed — CJC-1295: 12.0 mg (59.8 % of the 20 mg combined label)
Assayed — Ipamorelin: 12.7 mg (63.6 % of the 20 mg combined label)
Laboratory specification · assayed content: 90 – 110 % of 20 mg
On the sum of the components: Components sum to 24.7 mg (123.5 % of 20 mg); the certificate sets its 90 – 110 % specification against the combined label and states no pass/fail.
On the assayed figure: Components are reported individually; the specification applies to the combined label. The certificate states each component separately and gives no combined assayed figure.
Peptide to excipients: 24.7 : 102.3 mg (1:4.1) (USP recommended ratios of (1:0) to (1:10))
Total mass in the vial: 127 mg
General appearance · USP <630>: white powder (laboratory specification white powder)
Visual description: Small clear vial: white sample, silver label, silver crimp, yellow plastic cap.
Peak 1 · HPLC at 280 nm: retention time 4.854 min, area 2925.5 mAU*s
Peak 2 · HPLC at 280 nm: retention time 7.088 min, area 416.9 mAU*s
On the peak table: The certificate tabulates the peaks of its chromatogram and does not say which peak is which component; a peak's area is not a mass.